Hy-Vee CEO co-chairs Iowa health initiative
DES MOINES, Iowa — Supermarket chain Hy-Vee is joining an initiative to make Iowa the healthiest state by 2016, the company said.
The Healthiest State Initiative will encourage individuals, businesses, organizations and communities to work together in improving state residents’ health and well-being. According to the Gallup-Healthways Well-Being Index, Iowa ranks 19th in the country.
Hy-Vee CEO Ric Jurgens will serve as 1-of-3 co-chairs of the initiative, along with Wellmark Blue Cross and Blue Shield CEO John Forsyth and Doug Reichardt, chairman of the Iowa Sports Foundation and chairman emeritus of Holmes Murphy & Associates, an insurance firm.
The initiative is led by private business and has received endorsements from first lady Michelle Obama and Iowa Gov. Terry Branstad, who announced the initiative alongside Jurgens and other political leaders.
Sears appoints new CFO
HOFFMAN ESTATES, Ill. — Sears Holdings announced Tuesday that Robert Schriesheim will join the company as EVP and CFO. Schriesheim, who starts with the company immediately as EVP, will assume his responsibilities as CFO, effective Aug. 22.
Schriesheim, 51, most recently was CFO for Hewitt Associates, leading the company’s global financial and administrative roles until its merger with Aon.
Prior to joining Hewitt, Schriesheim was EVP, CFO and a director of Lawson Software, the world’s third-largest, publicly-traded enterprise resource planning software company, where he helped lead a five-year corporate transformation. During this period, his strategic, operational and financial skills helped Lawson drive material improvement in gross margins and triple its operating margins, while investing in new products, quality upgrades and acquisitions to fund growth initiatives.
"We’re delighted to have Rob join our team at Sears Holdings. Rob is a proven global chief financial officer and brings excellent experience at driving operating performance and delivering value in complex organizations undergoing rapid change," Sears Holdings president and CEO Lou D’Ambrosio said. "Rob brings a passion for performance, creating value, and developing people. His leadership and financial acumen, together with his track record of delivering results, will be important skills as we accelerate our transformation and deliver compelling value to our customers, associates, and shareholders."
Schriesheim holds a master’s degree in business administration from the University of Chicago Booth School of Business and a bachelor’s degree in chemistry from Princeton University. He also is a member of The Economic Club of Chicago and The Chicago Club. He has served on numerous public corporate boards and currently is a director of Skyworks Solutions.
Study: Effient reduces cardiovascular risk among younger, heavier patient cohort
INDIANAPOLIS — A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.
Researchers examined results from the "TRITON-TIMI 38" study of Effient (prasugrel), focusing on 10,804 patients who belonged to the "core clinical cohort," meaning patients who were younger than 75, weighed 132 lbs. or more and who had no prior history of stroke or transient ischemic attack, an episode in which a person has stroke-like symptoms for up to one or two hours; transient ischemic attacks are a warning sign of possible future strokes. The Food and Drug Administration approved Effient in 2009.
The analysis showed that among patients in the core clinical cohort, those taking Effient had a 26% reduction in their risk of heart attacks, cardiovascular death or stroke compared with those taking Plavix (clopidogrel), a drug in the same class made by Bristol-Myers Squibb and Sanofi.